Ras inhibitors
US11952352B2 · kind B2 · utility
4Cited by
26References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 30, 2023 |
| Grant date | Apr 9, 2024 |
| Priority date | — |
| Expiry date | Jan 30, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The disclosure features macrocyclic compounds, and pharmaceutical compositions and protein complexes thereof, capable of inhibiting Ras proteins, and their uses in the treatment of cancers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.